The XRCC4 rs1805377 polymorphism is not associated with the risk of cancer: An updated meta-analysis.

Xin-Yuan ZhangXiao-Han WeiBao-Jie Wang Jun Yao

Published in: The Journal of international medical research (2021)

Through this meta-analysis, we found no association between the rs1805377 polymorphism and cancer occurrence. This may provide useful information for relevant future studies into the etiology of cancer.

Keyphrases

systematic review
papillary thyroid
squamous cell
case control
meta analyses
lymph node metastasis
randomized controlled trial
healthcare
dna repair
oxidative stress
social media